Osaic Holdings
BHVN

Osaic Holdings’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Osaic Holdings’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,691
Closed -$407K – 7804
2022
Q3 		$407K Sell
2,691
-843
-24% -$125K ﹤0.01% 3092
2022
Q2 		$515K Sell
3,534
-313
-8% -$40K ﹤0.01% 2893
2022
Q1 		$3.02M Buy
3,847
+101
+3% +$12.6K 0.01% 1590
2021
Q4 		$517K Buy
3,746
+214
+6% +$27.2K ﹤0.01% 3032
2021
Q3 		$491K Buy
3,532
+1,257
+55% +$157K ﹤0.01% 3053
2021
Q2 		$221K Buy
2,275
+137
+6% +$11.1K ﹤0.01% 3790
2021
Q1 		$146K Buy
2,138
+1,278
+149% +$103K ﹤0.01% 4040
2020
Q4 		$74K Buy
860
+454
+112% +$38.5K ﹤0.01% 4272
2020
Q3 		$28K Sell
406
-289
-42% -$18.9K ﹤0.01% 4719
2020
Q2 		$50K Buy
695
+106
+18% +$5.64K ﹤0.01% 4194
2020
Q1 		$20K Buy
+589
New +$26.9K ﹤0.01% 4655

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Osaic Holdings's BHVN Position: Q4 2022 in Review

Osaic Holdings sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 2,691 shares — an estimated $407K sold.

Osaic Holdings first reported a position in BHVN in Q1 2020 and held it in 11 quarters. The position peaked at $3.02M in Q1 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Osaic Holdings reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Osaic Holdings sold 2,691 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $407K.
  • Osaic Holdings first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2020 and held it in 11 quarters.
  • Osaic Holdings's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $3.02M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.